• 1. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Acrylic acids and derivatives

Methyl 3-Ethoxyprop-2-enoate: A Comprehensive Overview

Methyl 3-ethoxyprop-2-enoate, also known by its CAS number 78681-80-8, is a versatile organic compound that has garnered significant attention in both academic and industrial research. This compound, classified as a propenoate ester, is widely recognized for its role in various chemical reactions and applications. The structure of methyl 3-ethoxyprop-2-enoate consists of a propenoic acid moiety with an ethoxy group at the third position and a methyl ester group, making it a valuable intermediate in organic synthesis.

Recent studies have highlighted the importance of methyl 3-ethoxyprop-2-enoate in the development of advanced materials and pharmaceuticals. Researchers have explored its potential as a precursor for synthesizing bioactive compounds, such as antibiotics and anti-inflammatory agents. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit promising anti-cancer properties, particularly in targeting specific oncogenic pathways.

In addition to its role in drug discovery, methyl 3-ethoxyprop-2-enoate has found applications in the field of polymer science. Its ability to undergo polymerization under specific conditions has led to the development of novel polymeric materials with enhanced mechanical and thermal properties. A notable example is its use in synthesizing biodegradable polymers for sustainable packaging solutions, as reported in a 2023 article in Polymer International.

The synthesis of methyl 3-ethoxyprop-2-enoate typically involves esterification reactions or alkylation processes, depending on the desired purity and scale of production. Recent advancements in catalytic methods have significantly improved the efficiency and selectivity of these reactions. For instance, the use of enzymatic catalysts has been shown to reduce reaction times and minimize byproduct formation, making the production process more environmentally friendly.

From an environmental perspective, methyl 3-ethoxyprop-2-enonate has been studied for its biodegradability and potential impact on ecosystems. Research conducted in 2023 revealed that under aerobic conditions, this compound undergoes rapid degradation, reducing its ecological footprint compared to other similar compounds.

In conclusion, methyl 3-Ethoxyprop-2-enonate (CAS No: 78681–80–8) is a multifaceted compound with diverse applications across various industries. Its role as an intermediate in organic synthesis, coupled with its potential in drug discovery and material science, underscores its importance in modern chemistry. As research continues to uncover new avenues for its utilization, this compound is poised to play an even greater role in advancing technological and medical innovations.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)